| SC 13G | 2024-02-22 | Logos Global Management LP | Adverum Biotechnologies, Inc. | 15,000,000 | 7.2% | EDGAR |
| SC 13G | 2024-02-15 | TCG Crossover GP II, LLC | Adverum Biotechnologies, Inc. | 20,763,572 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Venrock Healthcare Capital Partners III, L.P. | Adverum Biotechnologies, Inc. | 15,564,213 | 7.5% | EDGAR |
| SC 13G/A | 2024-02-14 | COMMODORE CAPITAL LP | Adverum Biotechnologies, Inc. | 10,000,000 | 9.9% | EDGAR |
| SC 13G | 2024-02-14 | Vivo Opportunity Fund Holdings, L.P. | Adverum Biotechnologies, Inc. | 15,000,000 | 7.2% | EDGAR |
| SC 13G/A | 2024-02-13 | BANK OF AMERICA CORP /DE/ | Adverum Biotechnologies, Inc. | 4,425,895 | 4.4% | EDGAR |
| SC 13G/A | 2024-02-12 | MORGAN STANLEY | Adverum Biotechnologies, Inc. | 5,150,496 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Adverum Biotechnologies, Inc. | 6,124,272 | 6.1% | EDGAR |
| SC 13G | 2024-02-09 | Frazier Life Sciences Public Fund, L.P. | Adverum Biotechnologies, Inc. | 5,003,125 | 2.4% | EDGAR |
| SC 13G/A | 2024-02-07 | BML Investment Partners, L.P. | Adverum Biotechnologies, Inc. | 4,554,252 | 2.2% | EDGAR |
| SC 13G | 2023-07-24 | Venrock Healthcare Capital Partners III, L.P. | Adverum Biotechnologies, Inc. | 5,899,489 | 5.9% | EDGAR |
| SC 13G | 2023-04-20 | COMMODORE CAPITAL LP | Adverum Biotechnologies, Inc. | 6,158,141 | 6.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | Adverum Biotechnologies, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Soleus Capital Master Fund, L.P. | Adverum Biotechnologies, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-14 | BANK OF AMERICA CORP /DE/ | Adverum Biotechnologies, Inc. | 5,591,896 | 5.6% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Adverum Biotechnologies, Inc. | 7,772,874 | 7.8% | EDGAR |
| SC 13G/A | 2023-02-08 | BML Investment Partners, L.P. | Adverum Biotechnologies, Inc. | 7,067,179 | 7.1% | EDGAR |
| SC 13G | 2023-02-08 | MORGAN STANLEY | Adverum Biotechnologies, Inc. | 7,135,052 | 7.2% | EDGAR |
| SC 13D/A | 2022-12-30 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 4,552,068 | 4.6% | EDGAR |